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Combining Xenoestrogens at Levels below Individual No-Observed-Effect
Concentrations Dramatically Enhances Steroid Hormone Action
Nissanka Rajapakse, Elisabete Silva, and Andreas Kortenkamp
Centre for Toxicology, School of Pharmacy, London, United Kingdom
The enormous discrepancies between the
high concentrations of xenoestrogens often
required to produce effects in laboratory
assays and their low levels in human tissues
and the environment have fueled the belief
that synergisms between these chemicals need
to be invoked to explain possible health risks
to humans and wildlife. However, initial
reports of strong synergisms between binary
combinations of estrogenic pesticides (Arnold
et al. 1996) could not be reproduced (Ashby
et al. 1997; Ramamoorthy et al. 1997) and
had to be withdrawn (McLachlan 1997).
Furthermore, numerous tissues contain potent
steroidal estrogens at biologically active levels.
This has led to the view that exposure to
xenoestrogens may not pose any harm because
they are unable to impact the strong effects of
steroidal estrogens (Safe 1995).
However, the perceived “weakness” (or
otherwise) of a xenoestrogen alone does not
necessarily signal absence of risks, when con-
sidering the effects of xenoestrogens in rela-
tion to potent steroidal estrogens. In a recent
study of mixtures of estradiol and the weak
xenoestrogens bisphenol A and o,p´-DDT
(Rajapakse et al. 2001), we found that both
the hormone and the xenoestrogens con-
tributed in equal measure to the observed
combination effects when combined at con-
centrations that produced similar responses.
Furthermore, model calculations carried out
by our group suggested that combinations of
a large number of xenoestrogens might
modulate the effects of 17β-estradiol, even
when each individual xenoestrogen is present
at concentrations that alone would not pro-
duce measurable effects (Kortenkamp and
Altenburger 1999). In view of the implica-
tions for hazard assessment, we set out to test
this idea experimentally.
Mixture experiments involving a large
number of chemicals place very high demands
on the reproducibility of biologic responses.
To meet these requirements, we used the yeast
estrogen screen (YES) (Routledge and Sumpter
1996), which has proven to yield highly repro-
ducible results (Payne et al. 2000; Rajapakse
et al. 2001).
Before we could proceed with the studies
presented here, we had to investigate whether
weak xenoestrogens, in the absence of the
potent hormone 17β-estradiol, would act
together when combined at levels below no-
observed-effect concentrations (NOECs).
Furthermore, information about the validity
of a variety of concepts for the prediction and
assessment of xenoestrogen mixture effects was
required. In a recent study involving eight
weak xenoestrogens and the YES assay, we
addressed these points (Silva et al. 2002). We
were able to show that significant mixture
effects occurred when the chemicals were
mixed at levels equal to 50% of their individ-
ual NOEC. The effects of combinations of
estrogenic chemicals were predicted on the
basis of concentration–response relationships
of individual mixture components (“fixed
mixture ratio design”) (Altenburger et al.
2000; Backhaus et al. 2000). We found that
the additivity predictions calculated by using
the concept of concentration addition (CA)
(Loewe and Muischnek 1926) proved to agree
excellently with experimental observations. In
contrast, the competing concept of indepen-
dent action (Bliss 1939) led to considerable
underestimations of measured effects (Silva et
al. 2002). Thus, CA can be used with conﬁ-
dence for the prediction and assessment of the
joint effects of xenoestrogens in the YES assay.
When dealing with agents that exhibit sig-
moidal concentration–response curves, as is
the case with estrogenic chemicals, it is not
possible to calculate expected additive effects
by forming the arithmetic sum of individual
responses (effect summation; ES). Although
the pitfalls of this approach have been dis-
cussed extensively (Berenbaum 1985;
Kortenkamp and Altenburger 1998; Payne et
al. 2000), its shortcomings are not widely
acknowledged. For this reason, we have
included ES here for purposes of comparison.
The clariﬁcation of the above issues pro-
vided a firm basis for the studies presented
here. We created a pool of 11 weak xeno-
estrogens with a mixture ratio in proportion
to the EC01 (concentration producing 1% of
the maximally inducible effect in the YES
assay) of all individual components. This
ensured that no single xenoestrogen con-
tributed disproportionately to the overall
mixture effect. The 11 xenoestrogens were in
turn mixed with 17β-estradiol at defined
mixture ratios, ranging from 1:25,000 to
1:100,000 (17β-estradiol:pool of xenoestro-
gens). Predictions were calculated by using
CA and then tested experimentally.
We determined concentrations of test
agents that failed to produce measurable
effects relative to untreated yeast by establish-
ing NOECs and by using regression-based
approaches that estimate low effects by inter-
polation on the basis of entire dose–response
curves (benchmark concentrations) (Moore
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The low potency of many man-made estrogenic chemicals, so-called xenoestrogens, has been used
to suggest that risks arising from exposure to individual chemicals are negligible. Another argu-
ment used to dismiss concerns of health effects is that endogenous steroidal estrogens are too
potent for xenoestrogens to contribute significantly to estrogenic effects. Using a yeast reporter
gene assay with the human estrogen receptor α, we tested these ideas experimentally by assessing
the ability of a combination of 11 xenoestrogens to affect the actions of 17β-estradiol.
Signiﬁcantly, each xenoestrogen was present at a level well below its no-observed-effect concentra-
tion (NOEC). To derive accurate descriptions of low effects, we recorded concentration–response
relationships for each xenoestrogen and for 17β-estradiol. We used these data to predict entire
concentration–response curves of mixtures of xenoestrogens with 17β-estradiol, assuming additive
combination effects. Over a large range of concentrations, the experimentally observed responses
decisively conﬁrmed the model predictions. The combined additive effect of the 11 xenoestrogens
led to a dramatic enhancement of the hormone’s action, even when each single agent was present
below its NOEC. Our results show that not even sub-NOEC levels of xenoestrogens can be con-
sidered to be without effect on potent steroidal estrogens when they act in concert with a large
number of similarly acting chemicals. It remains to be seen to what degree these effects can be
neutralized by environmental chemicals with antiestrogenic activity. Nevertheless, potential
human and wildlife responses induced by additive combination effects of xenoestrogens deserve
serious consideration. Key words: 17β-estradiol, additivity, mixture effects, xenoestrogens, yeast
estrogen screen (YES). Environ Health Perspect 110:917–921 (2002). [Online 12 August 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p917-921rajapakse/abstract.htmland Caux 1997; Van der Hoeven 1997). We
have approximated “insignificant effects” as
EC01 values.
Finally, it was necessary to restrict the
selection of test agents to those that produced
a maximal response similar to 17β-estradiol.
The reason for this constraint lies in the
mathematical features of the CA concept: CA
estimates concentrations of mixtures (and sin-
gle agents) associated with predetermined
effect levels. With estrogenic chemicals that
yield only submaximal effects at saturating
concentrations, this would have led to mix-
ture effect prediction curves not exceeding
the lowest maximal effect of any single mix-
ture component. In many cases this might
have complicated the assessment of agree-
ment between experimental observation and
predicted mixture effects. To avoid such
ambiguities, we used only xenoestrogens with
maximal effects of at least 60% of that seen
with 17β-estradiol in mixture studies.
Materials and Methods
Chemicals. We purchased 17β-estradiol
(≥ 98% pure) and genistein (98% pure) from
Sigma Chemical Company Ltd. (Dorset,
UK); resorcinol monobenzoate (99% pure),
phenyl salicylate (99% pure), benzyl-4-
hydroxyparabene (99% pure), and 2,4-dihy-
droxybenzophenone (99% pure) from
Aldrich Chemicals (Dorset, UK); bisphenol A
(4,4´-isopropylidene diphenol; 97% pure)
from Acros Organics (Geel, Belgium); and
4´-chlorobiphenyl-4-ol (> 95% pure), 2,3,4-
trichlorobiphenyl (99.9% pure), 2´,5´-
dichlorobiphenyl-4-ol (> 95% pure),
2,3,4,5-tetrachlorobiphenyl (> 97% pure),
and 2´,3´,4´,5´-tetrachlorobiphenyl-4-ol
(95% pure) from Ultra Scientific (North
Kingston, RI, USA). We used the agents as
supplied; we prepared 1 mM stock solutions
in HPLC–analyzed absolute ethanol
(Mallinckrodt Baker, Deventer, Holland).
Stock solutions of the mixtures were also
made at 1 mM by combining appropriate
volumes of stock solutions. Stocks and subse-
quent dilutions were kept in critically cleaned
glass containers and stored at –20°C. All
other chemicals used were research grade
from Sigma Chemical Company, unless oth-
erwise stated. We selected many of the com-
pounds that were used by Miller et al. (2001).
The recombinant yeast estrogen screen. We
followed a protocol developed by Routledge
and Sumpter (1996) exactly as described by
Rajapakse et al. (2001). We obtained single-
agent data from at least three experiments run
in duplicate, and mixture samples were run in
duplicate on at least two separate occasions.
Nominal concentrations were used.
Dosimetry. We constructed scatter plots
of corrected absorbance values (effect) versus
log concentration and analyzed them using
the best-fit approach (Scholze et al. 2000).
We selected the best fit from a number of
nonlinear regression models for final data
analysis. In these studies, we used the asym-
metric (or three-parameter) Hill function:
[1]
where Min and Max are the minimal and
maximal observed effects, respectively; c is the
concentration of test agent; EC50 is the con-
centration of test agent yielding half-maximal
effects; and p is the slope parameter. The 95%
conﬁdence intervals (CIs) of the best estimate
of mean effects were also calculated. Nonlinear
curve ﬁtting was carried out using SigmaPlot
(version 5.0; SPSS Inc., Chicago, IL, USA).
Determinations of low effect concentra-
tions. We used Dunnett’s t-test (Dunnett
1955) to estimate NOECs. EC01 values were
determined by interpolation using the best-ﬁt
regression model for each tested chemical.
Calculation of predicted mixture effects.
After comprehensive concentration–response
analysis of the single agents, the responses of
mixtures of 17β-estradiol with the xenoestro-
gen pool (i.e., all 11 chemicals combined in
proportion to their EC01 values; Table 1) were
predicted assuming additive combination
effects. Despite the numerous reports high-
lighting the shortcomings of ES, it is still
being applied incorrectly. For this reason, the
expected effects for three mixture ratios were
calculated using not only the appropriate con-
cept of CA but also ES, in the hope of
demonstrating experimentally its failure under
these conditions. A detailed description of the
concepts and their mathematical derivation
was published by Rajapakse et al. (2001).
Assessing mixture predictions. The validity
of the predicted mixture effects was evaluated
experimentally using 1:100,000, 1:50,000,
and 1:25,000 (17β-estradiol:xenoestrogen
pool) mixtures. Master stock solutions
(1 mM) were made and serially diluted to
cover the range of concentrations modeled in
the predictions.
The impact of xenoestrogens in mixtures
with 17β-estradiol becomes discernible when
mixture effects are plotted in terms of the
concentration of steroid hormone in the mix-
ture, along with the dose–response curve of
the hormone alone. A shift of the mixture
dose–response curve to the left of the 17β-
estradiol curve represents the impact of the
xenoestrogens. The modulation is considered
signiﬁcant when the 95% CIs for the mixture
and 17β-estradiol regressions do not overlap.
Results
Concentration–response analysis of individual
mixture components. All tested agents induced
activation of the human estrogen receptor α
(hERα) in a concentration-dependent manner.
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Table 1. Summary of asymmetric Hill parametersa for test agents in the YES. 
Fraction in NOEC EC01 X50
Compoundsb XE mixc (µM) (µM)d (µM) p-Value Max
1. 17β-Estradiol — 1.15  × 10–5 2.3 × 10–5 1.8 × 10–4 2.273 1.657
2. 2´,3´,4´,5´-Tetrachlorobiphenyl-4-ol 0.0004 0.005 0.008 0.061 2.202 1.711
3. 2´,5´-Dichlorobiphenyl-4-ol 0.0009 0.011 0.011 0.060 2.699 1.713
4. 4´-Chlorobiphenyl-4-ol 0.0054 0.054 0.074 0.599 2.161 1.665
5. Genistein 0.0074 0.038 0.086 0.595 2.337 1.672
6. 2,4-Dihydroxybenzophenone 0.0144 0.073 0.124 0.702 2.617 1.713
7. Benzyl-4-hydroxyparabene 0.0102 0.116 0.130 0.787 2.519 1.703
8. 2,3,4,5-Tetrachlorobiphenyl 0.0159 0.295 0.177 4.921 1.324 1.493
9. Bisphenol  A 0.0554 0.422 0.632 2.879 2.983 1.676
10. Resorcinol monobenzoate 0.1950 0.990 2.236 13.49 2.546 1.765
11. 2,3,4-Trichlorobiphenyl 0.1592 1.501 2.420 30.13 1.755 1.522
12. Phenyl salicylate 0.5360 9.486 8.824 53.66 2.355 1.232
13. Sum (excluding 1) 1.000 13 14.7 — — —
Abbreviations, Max, maximum; XE, xenoestrogen.
aDeﬁned in “Materials and Methods”; absorbance units for Max. bNumbers correspond to those in Figure 1. cProportion
of each component in “xenoestrogen pool” before combining with estradiol at ratios described in the text. dConcentration
producing effect 0.017 absorbance units (i.e., 1% of maximal response in YES).
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Figure 1. Concentration–response curves for the 11
xenoestrogens and 17β-estradiol in the YES assay,
showing the best-ﬁt regression models (asymmetric
Hill function). AU, absorbance units. Test agents:
1) 17β-estradiol; 2) 2´,3´,4´,5´-tetrachlorobiphenyl-4-ol;
3) 2´,5´-dichlorobiphenyl-4-ol; 4) 4´-chlorobiphenyl-4-
ol; 5) genistein; 6) 2,4-dihydroxbenzophenone; 7) ben-
zyl-4-hydroxyparabene; 8) 2,3,4,5-tetrachlorobiphenyl;
9) bisphenol A; 10) resorcinol monobenzoate;
11) 2,3,4-trichlorobiphenyl; 12) phenyl salicylate. There was relatively little variation in the
responses produced by the test chemicals. The
regression lines of all the mixture components
were of similar shapes and slopes, with the
exception of bisphenol A, 2,3,4-trichloro-
biphenyl, and phenyl salicylate, which pro-
duced somewhat shallower curves (Figure 1).
However, there were considerable variations
in potency. For example, the median effect
concentration of 17β-estradiol was approxi-
mately 350 times lower than that of the most
potent tested xenoestrogen, 2´,3´,4´,5´-tetra-
chlorobiphenyl-4-ol, and over 300,000 times
lower than that of phenyl salicylate, the weak-
est of all tested agents. The concentration–
response data for 2,3,4-trichlorobiphenyl and
phenyl salicylate did not show the leveling off
normally expected to occur at higher concen-
trations because, due to concerns of limited
aqueous solubility, we did not test concentra-
tions above 100 µM. 
Parameters of the regression models and
the mixture ratio of the pool of the 11 xenoe-
strogens are summarized in Table 1.
Estimation of low effect concentrations.
We have estimated low effect concentrations
of all tested chemicals in two ways: a) NOECs
were determined using Dunnett’s test, and b)
concentrations producing 1% of the maxi-
mum induced effect in the YES assay (i.e., 1%
of 1.765 absorbance units, given by saturating
concentrations of resorcinol monobenzoate)
were calculated.
As shown in Table 1, the low effect con-
centrations estimated using the two methods
agreed well, although the NOECs of most
chemicals were slightly lower than their corre-
sponding EC01.
Prediction and assessment of mixture
effects. To avoid one xenoestrogen con-
tributing disproportionately to the overall
combination effect, we made a pool of
xenoestrogens by mixing the agents in pro-
portion to their EC01 values. In turn, we
combined this “pool” with 17β-estradiol at
mixture ratios of 1:100,000, 1:50,000, and
1:25,000 (17β-estradiol:xenoestrogen pool).
On the basis of the relative prevalence of each
chemical in the mixture and of their concen-
tration–response relationships, we calculated
mixture effect predictions using CA and ES.
The predictions were computed assuming
additive combination effects and then tested
experimentally.
There was good agreement between
observed combination effects and those pre-
dicted by the CA concept (Figure 2). Thus,
the combined effect of all the xenoestrogens
and 17β-estradiol can be called additive. In
line with expectation, the observed mixture
concentration–response curves shifted to
lower concentrations, as the relative amount
of 17β-estradiol increased (median effect con-
centrations were 6.2, 4.5, and 3.2 µM for the
1:100,000, 1:50,000, and 1:25,000 17β-estra-
diol:xenoestrogen pool, respectively).
In contrast, the predictions calculated
using ES consistently and systematically under-
estimated the experimentally observed combi-
nation effects, independent of effect level.
Furthermore, ES was conspicuously unable to
model the leveling off of responses usually seen
at high concentrations. Using ES as the assess-
ment model, we would have concluded, erro-
neously, that the xenoestrogen–estradiol
mixtures acted synergistically, because the
observed combination effects exceeded those
predicted by ES.
Impact of xenoestrogens on the effects of
17β-estradiol. Due to the high potency of
17β-estradiol, it is conceivable that the
observed effects of the xenoestrogen–estradiol
mixtures were almost entirely due to the
action of the steroid hormone. Whether or
not this is the case is not immediately obvious
from the plots of mixture effects against the
total concentration of all mixture compo-
nents shown in Figure 2. To delineate the
effect of the hormone from the effects con-
tributed by the xenoestrogen pool, we nor-
malized the total mixture concentrations for
17β-estradiol levels and plotted the observed
responses against the 17β-estradiol content of
Articles • Impact of xenoestrogen mixtures on 17β-estradiol
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Figure 2. Predicted and observed mixtures effects of mixtures of 17β-estradiol and 11 xenoestrogens. AU: absorbance units. The xenoestrogens were pooled in pro-
portion to their EC01 values before being combined with 17β-estradiol at mixture ratios of (A) 1:100,000; (B) 1:50,000 and (C) 1:25,000 17β-estradiol:xenoestrogen pool.
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Figure 3. The impact of xenoestrogens on the effects of 17β-estradiol (E2) in three mixtures: (A) 1:100,000, (B) 1:50,000, and C) 1:25,000 E2:xenoestrogen pool. AU,
absorbance units. Best ﬁts, with 95% conﬁdence belts, to the experimentally observed mixture data are plotted in terms of the E2 concentrations, alongside the
concentration–response curve for E2 alone. The arrows in (B) indicate the concentration and the corresponding effects highlighted in Figure 4.
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
C
o
r
r
e
c
t
e
d
 
a
b
s
o
r
b
a
n
c
e
 
(
A
U
) A B C
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
C
o
r
r
e
c
t
e
d
 
a
b
s
o
r
b
a
n
c
e
 
(
A
U
)
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
C
o
r
r
e
c
t
e
d
 
a
b
s
o
r
b
a
n
c
e
 
(
A
U
)
10–5
Concentration (µM) Concentration (µM) Concentration (µM)
E2 in
mixture
E2
E2 in
mixture
E2
E2 in
mixture
E2
10–4 10–3 10–5 10–4 10–3 10–5 10–4 10–3the mixtures. The resulting best-ﬁt regression
curves were then compared to that of the hor-
mone on its own (Figure 3). If the xenoestro-
gens contributed significantly to the total
combination effect, increases in response,
resulting in displacements of the mixture
curves toward lower concentrations, would be
expected. The extent of this leftward shift rel-
ative to the 17β-estradiol curve should be
more pronounced, the higher the xenoestro-
gen content of the mixtures.
These expectations were borne out by our
experimental observations. With all three
mixtures, the contribution of the xenoestro-
gens revealed itself as a shift of the mixture
concentration–response curves to the left of
the 17β-estradiol curve. This shift was most
notable in the 1:100,000 mixture, in which
the proportion of xenoestrogens was highest.
Even with the 1:25,000 mixture, the xeno-
estrogens significantly modulated the action
of the steroid hormone, judged by the lack of
overlap of the respective 95% CIs of the best-
ﬁtted regression models.
Modulation of the effects of 17β-estradiol
by xenoestrogens at concentrations below
individual NOECs. We became interested in
comparing the joint effects of xenoestrogen–
estradiol mixtures with the responses expected
to occur after administration of each compo-
nent at concentrations well below the individ-
ual NOEC. As shown by the data compiled
in Table 1, the total mixture concentrations
resulting from combining all 11 xenoestro-
gens and 17β-estradiol at their NOECs or
EC01 levels are 13 and 14.7 µM, respectively.
Figure 4 shows the effect of 5 µM of the
1:50,000 mixture. This concentration was
chosen because it lies on the linear portion of
the mixture concentration–response curve
and is the lowest tested concentration where
the dose–response curves of the mixture and
of 17β-estradiol are parallel. Additionally, this
concentration is well below the sum of the
NOECs and EC01 values of the xenoestro-
gens in the mixture. We can therefore safely
assume that none of the xenoestrogens would
have produced effects detectable with the YES
assay when applied singly at these levels.
Figure 4 also shows the responses
expected to result from the levels of 17β-
estradiol present in the mixture. Crucially,
combination with 11 weak xenoestrogens led
to dramatic enhancements of mixture
responses, although each of the 11 xenoestro-
gens was present at levels well below those
that induce measurable responses. There was
more than a doubling of effects relative to
those of 17β-estradiol.
It becomes immediately obvious from
Figure 4 that calculation of combination
effects by computing the arithmetic sum of
individual responses (ES) led to dramatic
underestimation of observed joint effects. In
contrast, CA yielded a prediction that agreed
well with experimental observation.
Discussion
Considering the feasibility of multicompo-
nent mixture studies involving more than 10
chemicals, there were initial concerns that
multiplication of errors would undermine the
predictability of joint effects. However, our
study shows that it is possible to predict accu-
rately the joint effects of multicomponent
mixtures of xenoestrogens. Together with ear-
lier observations from our laboratory (Silva et
al. 2002), the data presented here conﬁrm the
usefulness of CA in anticipating combination
effects produced in the YES assay. With the
1:50,000 mixture, there was considerable
overlap between the predicted concentra-
tion–response curve and the 95% CI of the
regression model (Figure 2). Mainly because
of the very tight CIs of the regression models
for observed mixture effects, the predicted
curves for the 1:100,000 and the 1:25,000
mixtures failed to meet the overlap criterion,
but they were close enough to the observed
values to justify the conclusion of additive
joint effects. To a large degree, the small dif-
ferences between prediction and observation
were due to the low biologic variability of the
YES assay. It remains to be seen whether
results of similar quality can be achieved with
bioassays that show greater variability.
Perhaps the most striking finding of our
study is the demonstration that large numbers
of weak xenoestrogens are able to modulate
signiﬁcantly the effects of the potent steroidal
estrogen 17β-estradiol. This modulation
occurred even when each individual xenoe-
strogen was present at levels that did not
induce measurable effects, well below the
individual NOEC and EC01 values. Although
it may at first appear paradoxical, this phe-
nomenon can be explained in terms of the
premises of the CA concept. The concept
assumes that all components of a mixture act
in a similar way. From a pharmacologic point
of view, they can be thought of as behaving as
dilutions of one another. Thus, in interacting
with the estrogen receptor, each component
will add to the overall joint effect in propor-
tion to its individual potency and its concen-
tration. It follows that infinitesimally low
concentrations of an agent will contribute to
the mixture effect, even though, upon admin-
istration on its own, no response (zero effect)
will be produced. If the number of agents is
sufficiently large, their concentrations will
combine to produce measurable responses.
Provided these responses are sufﬁciently large,
effect modulations of potent steroid estrogens
will occur, as observed here. Simple addition
of effects, as in the ES method, is unable to
describe the behavior of mixtures of xenoe-
strogens and 17β-estradiol (Figure 4) and will
underestimate biologic responses (Berenbaum
1985; Kortenkamp and Altenburger 1999;
Silva et al. 2002).
It was our intention to model a scenario in
which all components of a mixture interact
with the same receptor, the hERα, in the
genetic context of the yeast cell reporter gene
construct. Our results show clearly that under
such conditions, not even concentrations
below NOECs can be considered to be with-
out effect on steroidal estrogens, provided
exposure is to sufficiently large numbers of
receptor agonists. Due to the characteristics of
the YES assay, however, the inﬂuence of other
signal transduction pathways and effector
chains responsible for estrogen-related effects
(and their inhibition) could not be captured. It
is well recognized that the effects of steroid
hormone receptor agonists/antagonists not
only are determined by ligand–receptor bind-
ing but also depend on interactions with spe-
ciﬁc effector molecules (Katzenellenbogen et
al. 1996). One class of such effectors, accessory
proteins called coregulators, are able to modu-
late the transcriptional activity of steroid hor-
mone receptors, even in the absence of classical
ligands (reviewed by Robyr et al. 2000;
Rosenfeld and Glass 2001). It remains to be
seen how the convergence of ligand-dependent
and -independent mechanisms in different cel-
lular contexts might impact the joint effects of
xenoestrogens and related compounds. Similar
considerations apply to the possible antagoniz-
ing effects of chemicals such as coplanar poly-
chlorinated biphenyls, dioxins, and furans.
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Figure 4. The effects produced by each mixture
component at the concentrations present in 5 µM
of the 1:50,000 mixture. Also shown are the pre-
dicted mixture effects calculated by using ES and
CA and the observed mixture effect (MIX). Test
agents (individual concentration): 1) 17β-estradiol
(100 pM); 2) 2´,3´,4´,5´-tetrachlorobiphenyl-4-ol (1.9
nM); 3) 2´,5´-dichlorobiphenyl-4-ol (4.6 nM); 4) 4´-
chlorobiphenyl-4-ol (26.9 nM); 5) genistein (37.1
nM); 6) 2,4-dihydroxbenzophenone (71.9 nM);
7) benzyl-4-hydroxyparabene (71.9 nM); 8) 2,3,4,5-
tetrachlorobiphenyl (79.5 nM); 9) bisphenol A (276.4
nM); 10) resorcinol monobenzoate (974.7 nM);
11) 2,3,4-trichlorobiphenyl (795.9 nM); 12) phenyl
salicylate (2.68 µM). Error bars indicate the upper
95% confidence limit of responses. In view of the
good agreement between CA prediction and exper-
imental observation (MIX) the combined effect of
all agents may be called (concentration) additive.
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CompoundThese agents may oppose the effects of estro-
genic chemicals by down-regulating ERα
expression, up-regulating 17β-estradiol–
metabolizing enzymes, and altering the expres-
sion of estrogen-inducible genes (Gillesby and
Zacharewski 1998). It will be revealing to
investigate whether such effects occur at envi-
ronmentally relevant concentrations.
Taken together, our findings from this
and previous studies allow several intercon-
nected conclusions to be drawn. First, the
biologic effects of xenoestrogens cannot be
dismissed as insignificant solely on the basis
of their low potency compared with steroidal
estrogens. Considered in isolation, the contri-
bution of individual xenoestrogens at the
concentrations found in wildlife and human
tissues will always be small. However, such
reasoning cannot be used to support claims of
negligible health risks from weak xenoestro-
gens, because the number of xenoestrogens
present in wildlife and humans is unknown
but likely to be very large. Whether there are
risks associated with xenoestrogens depends
also on the inﬂuence of chemicals that antag-
onize estrogenic effects. It remains to be seen
whether these chemicals, at environmentally
relevant concentrations, are able to neutralize
the effects of xenoestrogens.
Second, the fascination with synergistic
effects that has gripped the endocrine disruptor
ﬁeld in the wake of the paper by Arnold et al.
(1996) is misguided. It has led to a disregard of
the significance of seemingly unspectacular
additive combination effects. Our results show
clearly that additivity is important and
deserves serious attention in the assessment of
chemicals with estrogenic activity.
Third, by not taking combination effects
into account, signiﬁcant underestimations of
the effects associated with exposure to xenoe-
strogens are likely. In our experimental
model, we have demonstrated in principle
that every xenoestrogen, however weak, may
add incrementally to the total estrogenic
effect, even at very low concentrations, and
even in the presence of potent endogenous
steroidal estrogens. Although the limitations
of our assay system are obvious (it is unable
to model antiestrogenic effects and transcrip-
tional activation in different cellular con-
texts), it is safe to conclude that the discourse
about endocrine disruptors cannot be limited
to single agents and their effects. There have
been reports of low-dose effects of estrogenic
chemicals (Howdeshell et al. 1999; vom Saal
et al. 1997). In most cases, however, the out-
come of single-agent hazard and risk assess-
ment exercises is the conclusion that
individual estrogenic chemicals pose no haz-
ard because they are present at very low,
apparently ineffective levels in humans and
wildlife. A more balanced approach to risk
assessment is required. It is imperative to take
stock of the total estrogenic burden of
humans and wildlife and assess systematically
the possible inﬂuence of environmentally rel-
evant agents that may have the ability to neu-
tralize the effects of estrogens.
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